Mesa Laboratories MLAB Stock
Mesa Laboratories Price Chart
Mesa Laboratories MLAB Financial and Trading Overview
| Mesa Laboratories stock price | 124.76 USD |
| Previous Close | 119.15 USD |
| Open | 119.94 USD |
| Bid | 87.9 USD x 200 |
| Ask | 153.98 USD x 200 |
| Day's Range | 119.03 - 124.89 USD |
| 52 Week Range | 58.83 - 124.89 USD |
| Volume | 137.85K USD |
| Avg. Volume | 204.43K USD |
| Market Cap | 698.14M USD |
| Beta (5Y Monthly) | 0.93 |
| PE Ratio (TTM) | 141.77274 |
| EPS (TTM) | 0.85 USD |
| Forward Dividend & Yield | 0.64 (0.54%) |
| Ex-Dividend Date | August 31, 2026 |
| 1y Target Est | 117.5 USD |
MLAB Valuation Measures
| Enterprise Value | 827.25M USD |
| Trailing P/E | 141.77274 |
| Forward P/E | 12.148004 |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | 2.7956376 |
| Price/Book (mrq) | 3.700979 |
| Enterprise Value/Revenue | 3.313 |
| Enterprise Value/EBITDA | 18.207 |
Trading Information
Mesa Laboratories Stock Price History
| Beta (5Y Monthly) | 0.93 |
| 52-Week Change | 73.13% |
| S&P500 52-Week Change | 18.67% |
| 52 Week High | 124.89 USD |
| 52 Week Low | 58.83 USD |
| 50-Day Moving Average | 101.72 USD |
| 200-Day Moving Average | 91.99 USD |
MLAB Share Statistics
| Avg. Volume (3 month) | 204.43K USD |
| Avg. Daily Volume (10-Days) | 203.91K USD |
| Shares Outstanding | 5.6M |
| Float | 4.95M |
| Short Ratio | 1.84 |
| % Held by Insiders | 5.61% |
| % Held by Institutions | 96.17% |
| Shares Short | 324.1K |
| Short % of Float | 8.39% |
| Short % of Shares Outstanding | 5.79% |
Dividends & Splits
| Trailing Annual Dividend Rate | 0.64 |
| Trailing Annual Dividend Yield | 0.53% |
| 5 Year Average Dividend Yield | 51.00% |
| Payout Ratio | 0.7529 |
| Last Split Factor |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | March 31, 2026 |
| Most Recent Quarter (mrq) | June 30, 2026 |
| Next Fiscal Year End | March 31, 2027 |
Profitability
| Profit Margin | 1.92% |
| Operating Margin (ttm) | 11.69% |
| Gross Margin | 64.20% |
| EBITDA Margin | 18.19% |
Management Effectiveness
| Return on Assets (ttm) | 3.28% |
| Return on Equity (ttm) | 2.65% |
Income Statement
| Revenue (ttm) | 249.72M USD |
| Revenue Per Share (ttm) | 44.9 USD |
| Quarterly Revenue Growth (yoy) | 1.00% |
| Gross Profit (ttm) | 160.34M USD |
| EBITDA | 45.44M USD |
| Net Income Avi to Common (ttm) | 4.8M USD |
| Diluted EPS (ttm) | 0.88 |
| Quarterly Earnings Growth (yoy) | -40.30% |
Balance Sheet
| Total Cash (mrq) | 32.24M USD |
| Total Cash Per Share (mrq) | 5.76 USD |
| Total Debt (mrq) | 161.35M USD |
| Total Debt/Equity (mrq) | 85.48 USD |
| Current Ratio (mrq) | 1.794 |
| Book Value Per Share (mrq) | 33.71 |
Cash Flow Statement
| Operating Cash Flow (ttm) | 55.67M USD |
| Levered Free Cash Flow (ttm) | 53.38M USD |
Profile of Mesa Laboratories
| Country | United States |
| State | CO |
| City | Lakewood |
| Address | 12100 West Sixth Avenue |
| ZIP | 80228 |
| Phone | 303 987 8000 |
| Website | https://www.mesalabs.com |
| Industry | Scientific & Technical Instruments |
| Sector(s) | Technology |
| Full Time Employees | 717 |
Mesa Laboratories, Inc. develops, designs, manufactures, sells, and services life sciences tools and quality control products and services in North America, Europe, the Asia Pacific, and internationally. The Sterilization and Disinfection Control segment offers biological, chemical, and cleaning indicators, used to assess the effectiveness of sterilization, decontamination, disinfection, and cleaning processes in the pharmaceutical, medical device, and healthcare industries. This segment also provides sterility assurance testing and laboratory services to the dental and pharmaceutical industries. The Biopharmaceutical Development segment develops, manufactures, sells, and services automated systems for protein analysis (immunoassays) and peptide synthesis solutions. Its Clinical Genomics segment offers MassARRAY, a genetic analysis tool system, and related consumables, including chips, panels, and chemical reagent solutions used by clinical labs to analyze DNA samples for hereditary disease screenings, pharmacogenetics, oncology related applications, and toxicology research. The Biopharmaceutical Development segment provides automated systems, such as Gyrolab xPand and Gyrolab xPlore hardware and software, Gyrolab Bioaffy consumable microfluidic disks, Gyrolab kits and Rexxip buffers for protein analysis; and PurePep Symphony and Chorus instruments for peptide synthesis. Its Calibration Solutions segment offers quality control products to measure and calibrate critical parameters in applications, such as renal care, gas flow, environmental and process monitoring, and torque testing in pharmaceutical, laboratory, medical device, manufacturing, industrial, and environmental applications. This segment's products include continuous monitoring systems, data loggers, and torque testing systems under the DialyGuard, DryCal, DataTrace, and ViewPoint brands. Mesa Laboratories, Inc. was incorporated in 1982 and is headquartered in Lakewood, Colorado.
Q&A For Mesa Laboratories Stock
What is a current MLAB stock price?
Mesa Laboratories MLAB stock price today per share is 124.76 USD.
How to purchase Mesa Laboratories stock?
You can buy MLAB shares on the Tech Market Large exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Mesa Laboratories?
The stock symbol or ticker of Mesa Laboratories is MLAB.
Which industry does the Mesa Laboratories company belong to?
The Mesa Laboratories industry is Scientific & Technical Instruments.
How many shares does Mesa Laboratories have in circulation?
The max supply of Mesa Laboratories shares is 5.6M.
What is Mesa Laboratories Price to Earnings Ratio (PE Ratio)?
Mesa Laboratories PE Ratio is 146.77647000 now.
What was Mesa Laboratories earnings per share over the trailing 12 months (TTM)?
Mesa Laboratories EPS is 0.85 USD over the trailing 12 months.
Which sector does the Mesa Laboratories company belong to?
The Mesa Laboratories sector is Technology.
Mesa Laboratories MLAB included in indexes
| Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume |
|---|
| Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume | |
|---|---|---|---|---|---|---|---|
|
|
{{ item.price }} {{ item.price_usd }} |
{{ item.change_pct }}
|
{{ item.volume }} {{ item.volume_usd }} | {{ item.low }} {{ item.low_usd }} | {{ item.high }} {{ item.high_usd }} | {{ item.components_count }} - | {{ item.volume }} {{ item.volume_usd }} |
US Tech Composite
IXIC
US
|
26180.46 USD — |
+0.43
|
6.32B USD — | 26049.3 USD — | 26269.85 USD — | — - | 6.32B USD — |
US Tech Composite Total Return
XCMP
US
|
32315.97 USD — |
+0.44
|
— — | 32154.08 USD — | 32426.3 USD — | — - | — — |
US Tech US Broad Dividend Achiev
DAATR
US
|
8763.23 USD — |
+0.61
|
— — | 8743.24 USD — | 8778.95 USD — | — - | — — |
US Tech Global Select Market Com
NQGS
US
|
12848.65 USD — |
+0.42
|
— — | 12783.89 USD — | 12893.08 USD — | — - | — — |
US Tech Industrial
INDS
US
|
12912.88 USD — |
+0.81
|
— — | 12810.36 USD — | 12948.11 USD — | — - | — — |
- {{ link.label }} {{link}}


